Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran

Document Type: Original Article


1 Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Virology Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

3 Department of Medical Biotechnology & Molecular Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran

4 Esfarayen Faculty of Medical Sciences, Esfarayen, Iran

5 Department of Basic Sciences, Gonabad University of Medical Sciences, Gonabad, Iran

6 Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran


Objective(s): Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) with unknown etiology. Various genetics and environmental factors contribute to the pathogenesis of the disease. The interleukin-7 receptor alpha chain (IL-7Ra) was identified as the first non-major histocompatibility complex (non-MHC) MS susceptibility locus. In this study we are trying to find the association of IL-7Ragene polymorphisms with MS susceptibility in Eastern Iran.
Materials and Methods:A case-control study was performed in two provinces Sistan & Baluchistan and Khorasan with 219 patients and 258 unrelated matched healthy controls, using PCR-RFLP method for four single nucleotide polymorphisms (SNPs) rs7718919, rs11567685, rs11567686 and rs6897932 of IL-7Ra gene.
Results:We found a tendency toward association with genotyping analyses in SNP rs7718919 (P=0.048, OR=4.344, and 95% CI=0.892-21.146); also genotype and allele frequency in gender and MS subtype stratification were shown to have significant association with MS. Analysis of two provinces separately showed a significant difference in results of the allele and genotype frequencies. Moreover, haplotyping analysis showed that (GTGC) has an association only in the male secondary-progressive multiple sclerosis (SPMS) patients in comparison to the healthy controls (P=0.043, OR=0.413, and 95% CI=0.179–0.955).
Conclusion:IL7-Ra could be a susceptible gene to MS within the Eastern Iran population especially after MS and gender stratification.


1. Bahlo M, Booth DR, Broadley SA, Brown MA, Foote SJ, Griffiths LR, et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41:824-828.

2. Lassmann H, Brück W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001; 7:115-121.

3. Heidary M, Rakhshi N, Pahlevan Kakhki M, Behmanesh M, Sanati MH, Sanadgol N, et al. The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients. J Neurol Sci 2014; 343:41-45.

4. Bobowick AR, Kurtzke JF, Brody JA, Hrubec Z, Gillespie M. Twin study of multiple sclerosis. Neurology 1978; 28:978-985.

5. Sadovnick A, Dyment D, Ebers G, Risch N. Evidence for genetic basis of multiple sclerosis. Lancet 1996; 347:1728-1730.

6. Dyment DA, Ebers GC, Dessa Sadovnick A. Genetics of multiple sclerosis.  Lancet Neurol 2004; 3:104-110.

7. Akkad D, Hoffjan S, Petrasch-Parwez E, Beygo J, Gold R, Epplen J. Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. J Autoimmun 2009; 32:110-115.

8. Baranzini SE, Nickles D. Genetics of multiple sclerosis: swimming in an ocean of data. Curr Opin Neurol 2012; 25:239-245.

9. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, et al. Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39:1083-1091.

10. Zuvich RL, McCauley JL, Oksenberg JR, Sawcer SJ, De Jager PL, Aubin C, et al. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet 2010; 127:525-535.

11. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009; 18:767-778.

12. Weber F, Fontaine B, Cournu-Rebeix I, Kroner A, Knop M, Lutz S, et al. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes  Immun 2008; 9:259-263.

13. Sombekke M, van der Voort L, Kragt J, Nielsen J, Guzel H, Visser A, et al. Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis. Mult Scler J 2011; 17:922-30.

14. Kallio SP, Jakkula E, Purcell S, Suvela M, Koivisto K, Tienari PJ, et al. Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS. Hum Mol Genet 2009; 18:1670-1683.

15. Heidari M, Behmanesh M, Sahraian MA. Variation in SNPs of the IL7Ra Gene is Associated with Multiple Sclerosis in the Iranian Population. Immun Investig  2011; 40:279-289.

16. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002; 99:3892-3904.

17. Vandenbroeck K. Cytokine gene polymorphisms and human autoimmune disease in the era of genome-wide association studies. J Int Cytokine Res 2012; 32:139-151.

18. Broux B, Hellings N, Venken K, Rummens JL, Hensen K, Van Wijmeersch B, et al. Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrants. Genes Immun 2010; 11:326-333.

19. Tröster AI. Refining genetic associations in multiple sclerosis. Neurology 2006; 66:1830-1336.

20. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, et al. Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007; 39:1108-1113.

21. O'Doherty C, Kantarci O, Vandenbroeck K. IL7RA polymorphisms and susceptibility to multiple sclerosis. N Engl J Med 2008; 358:753-754.

22. Fang L, Isobe N, Yoshimura S, Yonekawa T, Matsushita T, Masaki K, et al. Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians. Neurology 2011; 76:2125-2127.

23. Kreft KL, Verbraak E, Wierenga-Wolf AF, Van Meurs M, Oostra BA, Laman JD, et al. The IL-7Rα pathway is quantitatively and functionally altered in CD8 T Cells in multiple sclerosis. J Immunol 2012; 188:1874-1883.

24. Friese MA, Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 2005; 128:1747-1763.

25. Booth D, Arthur A, Teutsch S, Bye C, Rubio J, Armati P, et al. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med 2005; 83:822-830.

26. Miri-Moghaddam E, Zadeh-Vakili A, Nikravesh A, Sanei Sistani S, Naroie-Nejad M. Sistani population: a different spectrum oF β-thalassemia mutations from other ethnic groups of Iran. Hemoglobin 2012; 2:1-10.

27. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi S-H, Akbari M, et al. Epidemiology of multiple sclerosis in Iran: A systematic review. Eur Neurol 2013; 70:356-363.

28. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121-127.

29. Teutsch SM, Booth DR, Bennetts BH, Heard RN, Stewart GJ. Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-α gene and their associations with multiple sclerosis. Eur J Hum Genet 2003; 11:509-515.

30. Lundström W, Highfill S, Walsh ST, Beq S, Morse E, Kockum I, et al. Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity. Proc Natl Acad Sci 2013; 110:E1761-E1770.

31. Hafler DA, Compston A, Sawcer S, Lander E, Daly M, De Jager P, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357:851-862.

32. Pandit L, Ban M, Sawcer S, Singhal B, Nair S, Radhakrishnan K, et al. Evaluation of the established non-MHC multiple sclerosis loci in an Indian population. Mult Scler J 2011; 17:139-143.

33. Baghizadeh S, Sahraian MA, Beladimoghadam N. Clinical and demographic factors affecting disease severity in patients with multiple sclerosis. Iran J Neurol 2013; 12:1.

34. Tremlett H, Zhao Y, Rieckmann P, Hutchinson M. New perspectives in the natural history of multiple sclerosis. Neurology 2010; 74:2004-2015.

35. Sivertseva S, Zhuravlev M, Murav'ev S, Boĭko A. [Epidemiology of multiple sclerosis in Tiumen'-region]. Zh Nevrol Psikhiatr Im SS Korsakova 2006; 3:22-25. Russian.

36. Sahraian MA, Pakdaman H, Harandi AA. Is it time to revise the classification of geographical distribution of multiple sclerosis? Iran J Neurol 2012; 11:77.